ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,460.48
      -0.41%
      US Tech 100
      19,181.60
      -0.43%
      Dow Jones
      39,118.86
      -0.12%
      Brent Oil
      84.85
      0.00%
      Bitcoin
      61,550.00
      1.08%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Altimmune Inc (ALT)

      7. Altimmune Inc (ALT) News

      ALT

      Altimmune (ALT)

      Altimmune Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ALT
      DateTimeSourceHeadlineSymbolCompany
      10/17/20237:30AMGlobeNewswire Inc.Altimmune to Participate at Two Upcoming Investor ConferencesNASDAQ:ALTAltimmune Inc
      09/29/20235:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALTAltimmune Inc
      09/29/20235:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALTAltimmune Inc
      09/29/20235:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALTAltimmune Inc
      09/29/20235:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALTAltimmune Inc
      09/29/20235:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALTAltimmune Inc
      09/28/20234:55PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALTAltimmune Inc
      09/26/20237:30AMGlobeNewswire Inc.Altimmune Announces Oral Presentation of Pemvidutide Clinical Data at 59th Annual Meeting of the European Association for the Study of DiabetesNASDAQ:ALTAltimmune Inc
      09/12/20237:30AMGlobeNewswire Inc.Altimmune Announces Completion of Dosing in the Phase 2 MOMENTUM Trial of Pemvidutide in Subjects with Obesity or OverweightNASDAQ:ALTAltimmune Inc
      08/30/20237:30AMGlobeNewswire Inc.Altimmune to Participate at Two Upcoming Investor ConferencesNASDAQ:ALTAltimmune Inc
      08/16/20234:14PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ALTAltimmune Inc
      08/16/20234:10PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ALTAltimmune Inc
      08/15/20236:46PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALTAltimmune Inc
      08/10/20234:06PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ALTAltimmune Inc
      08/10/20237:04AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALTAltimmune Inc
      08/10/20237:00AMGlobeNewswire Inc.Altimmune Announces Second Quarter 2023 Financial Results and Provides a Business UpdateNASDAQ:ALTAltimmune Inc
      08/03/20237:30AMGlobeNewswire Inc.Altimmune to Report Second Quarter 2023 Financial Results and Provide Business Update on August 10, 2023NASDAQ:ALTAltimmune Inc
      08/02/20235:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALTAltimmune Inc
      08/02/20235:51PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALTAltimmune Inc
      08/02/20235:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALTAltimmune Inc
      08/02/20235:47PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALTAltimmune Inc
      08/02/20235:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALTAltimmune Inc
      08/01/20237:30AMGlobeNewswire Inc.Altimmune Announces Initiation of Phase 2b IMPACT Trial Evaluating the Efficacy and Safety of Pemvidutide in Non-Alcoholic Steatohepatitis (NASH)NASDAQ:ALTAltimmune Inc
      07/06/20236:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALTAltimmune Inc
      06/16/20237:30AMGlobeNewswire Inc.Altimmune to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Tuesday, June 20th, 2023NASDAQ:ALTAltimmune Inc
      06/15/20237:30AMGlobeNewswire Inc.Altimmune Announces Oral Presentation of Pemvidutide Clinical Data in Treatment of NAFLD at Upcoming EASL International Liver Congress™ 2023NASDAQ:ALTAltimmune Inc
      05/11/20234:07PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ALTAltimmune Inc
      05/11/20237:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ALTAltimmune Inc
      05/11/20237:00AMGlobeNewswire Inc.Altimmune Announces First Quarter 2023 Financial Results and Provides a Business UpdateNASDAQ:ALTAltimmune Inc
      05/08/20237:30AMGlobeNewswire Inc.Altimmune to Participate at Two Upcoming Investor ConferencesNASDAQ:ALTAltimmune Inc
       Showing the most relevant articles for your search:NASDAQ:ALT